Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05463848
Title Surgical Pembro +/- Olaparib w TMZ for rGBM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors L. Nicolas Gonzalez Castro, MD, PhD
Indications

IDH-wildtype glioblastoma

glioblastoma

gliosarcoma

high grade glioma

Therapies

Olaparib + Pembrolizumab + Temozolomide

Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST